1. Home
  2. NUTX vs TVGN Comparison

NUTX vs TVGN Comparison

Compare NUTX & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$176.68

Market Cap

729.5M

Sector

Technology

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$0.38

Market Cap

89.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
TVGN
Founded
2011
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Blank Checks
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
729.5M
89.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NUTX
TVGN
Price
$176.68
$0.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$252.50
$5.00
AVG Volume (30 Days)
177.6K
1.4M
Earning Date
11-19-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
17.98
N/A
Revenue
$981,195,633.00
N/A
Revenue This Year
$108.77
N/A
Revenue Next Year
$3.69
N/A
P/E Ratio
$9.83
N/A
Revenue Growth
236.03
N/A
52 Week Low
$28.82
$0.36
52 Week High
$193.00
$1.92

Technical Indicators

Market Signals
Indicator
NUTX
TVGN
Relative Strength Index (RSI) 59.15 40.64
Support Level $162.59 $0.37
Resistance Level $180.76 $0.41
Average True Range (ATR) 14.03 0.03
MACD -1.24 0.00
Stochastic Oscillator 53.11 19.64

Price Performance

Historical Comparison
NUTX
TVGN

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: